Updated:
BioClinica
Clario, a part of Thermo Fisher Scientific, combines science-informed endpoint technology, global scale, and expert services to generate reliable clinical...
Overview
Clario, a part of Thermo Fisher Scientific, combines science-informed endpoint technology, global scale, and expert services to generate reliable clinical evidence for every trial phase.
General information
Location
Region
North America
Country
United States
City
Princeton
Corporate office
Princeton, NJ, United States
Additional offices
Montréal, QC, Canada
Sector focus
Frequently asked questions
What clinical trial endpoints does BioClinica support?
BioClinica’s platform covers cardiac safety (ECG, blood pressure, arrhythmia monitoring), medical imaging (CT, MRI, endoscopy, and AI-driven redaction), electronic clinical outcome assessments (eCOA) including neuroscience-specific modules, and respiratory function (site-based spirometry, virtual home spirometry, cough monitoring, oscillometry, and DLCO). The firm also markets a wearable-sensor solution under the Precision Motion line for mobility-based digital endpoints.
In how many countries does BioClinica operate?
The firm reports regulatory and operational presence in over 100 countries, with support available in more than 100 languages. Its main offices include Princeton, New Jersey, and Montréal, Quebec.
Who leads BioClinica’s scientific and operational teams?
BioClinica does not publicly name individual principals on its leadership page. The firm’s website references 'key opinion leaders' embedded across its medical imaging and scientific teams, but no single CEO or CIO is attributed to the BioClinica/Clario entity in the available sources.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: